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ABSTRACT
Lens epithelium-derived growth factor (LEDGF) or
p75 is a co-activator of general transcription and
also involved in insertion of human immunodefi-
ciency virus type I (HIV-1) cDNA into host cell
genome, which occurs preferentially to active tran-
scription units. These phenomena may share an
underlying molecular mechanism in common. We
report here that LEDGF/p75 binds negatively super-
coiled DNA selectively over unconstrained DNA. We
identified a novel DNA-binding domain in the protein
and termed it ‘supercoiled DNA-recognition domain’
(SRD). Recombinant protein fragments containing
SRD showed a preferential binding to supercoiled
DNA in vitro. SRD harbors a characteristic cluster
of lysine and glutamic/aspartic acid residues. A
polypeptide mimicking the cluster (K9E9K9) also
showed this specificity, suggesting that the cluster
is an essential element for the supercoil recognition.
eGFP-tagged LEDGF/p75 expressed in the nucleus
distributed partially in transcriptionally active
regions that were identified by immunostaining of
methylated histone H3 (H3K4me3) or incorporation
of Br-UTP. This pattern of localization was observed
with SRD alone but abolished if the protein lacked
SRD. Thus, these results imply that LEDGF/p75
guides its binding partners, including HIV-1 integ-
rase, to the active transcription site through recog-
nition of negative supercoils generated around it.
INTRODUCTION
Lens epithelium-derived growth factor (LEDGF, also
known as p75) had been associated with seemingly unre-
lated functions: a common nuclear autoantigen (1,2), a
transcriptional co-activator (3) and a growth/survival
factor of lens epithelial cells (4). More recently,
LEDGF/p75 was shown to bind with the integrase of
human immunodeﬁciency virus type I (HIV-1), which
catalyzes the integration of reverse-transcribed HIV
genome into host DNA (5). Subsequent studies have
revealed that LEDGF/p75 assists productive infection of
HIV-1 by targeting the integrase to chromatin (5–11).
Interestingly, genome-wide identiﬁcation of HIV integra-
tion hotspots in human genome indicated actively
transcribed genes (12–14). Later studies showed unequivo-
cally that LEDGF/p75 is responsible for the preferential
insertion of viral DNA into active transcription units
(15–17). The integrase binding domain (IBD) of
LEDGF/p75 binds other partner proteins as well:
Myc-interacting protein JPO2 (18), mixed-lineage
leukemia (MLL)/menin complex (19), a domesticated
transposase PogZ (pogo transposable element derived
protein with zinc ﬁnger) (20) and Cdc7-activator of
S-phase kinase (ASK) (21). Thus, IBD seems to function
as an association site for divergent factors that are
tethered to chromatin by LEDGF/p75. A tripartite
DNA binding element, comprised of a nuclear localization
signal (NLS) and two AT-hook motifs, was shown to
mediate DNA binding in vitro (22). An evolutionally
conserved N-terminal domain called PWWP is responsible
for chromatin binding although it does not bind free DNA
(22,23). Despite the recent progress in this ﬁeld, molecular
mechanisms that enable LEDGF/p75 to recognize actively
transcribed genomic regions are still unknown.
In the modern view of eukaryotic transcription,
template DNA is threaded through RNA polymerase
molecule that is docked at active transcription sites in
the nucleus. As a consequence, the template changes
higher order structure: negative supercoiling in the
receding upstream DNA and positive supercoiling in the
approaching downsteam DNA (24). Unrestrained super-
coils in the genome are drained by topoisomerases that
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However, a line of evidence suggests that topoisomerases
are insufﬁciently processive to keep pace with supercoil
generation during transcription (26,27). Recently, it was
clearly shown in human cells that dynamic DNA super-
coiling associated with transcription is detectable even in
the presence of normal concentrations of functional topo-
isomerases (28).
We report here that LEDGF/p75 selectively binds
supercoiled DNA through a novel domain desig-
nated supercoiled DNA-recognition domain (SRD) that
contains characteristic clusters of lysine and glutamic
acid/aspartic acid residues. When SRD was deleted, the
protein failed to show any preference toward supercoiled
DNA and abolished its co-localization with nuclear
domain of active transcription. The results suggest that
LEDGF/p75 recruits its binding partners to active tran-
scription units by recognizing superhelical DNA structure.
MATERIALS AND METHODS
Antibodies
Human sera from patients with Miller–Fisher syndrome
were screened for autoantibodies against rat supercoiled
DNA binding protein 75 (SBP75) by western blotting. IgG
was puriﬁed from positive sera using MAbTrap Kit (GE
Healthcare) and used at 7mg/ml in western blot analyses.
Epitope of the antibody was identiﬁed in a C-terminal
region (residues 386–528) of rat SBP75/LEDGF/p75
(Supplementary Figure S1). For immunocytochemical de-
tection, the human autoantibody was afﬁnity-puriﬁed
from the serum using His-tagged rat SBP75/LEDGF
immobilized on the HiTrap NHS-activated HP column
(GE Healthcare).
Anti-rat SBP75/LEDGF polyclonal antibody was
raised in a rabbit against the N-terminal fragment
(residues 1–197) of recombinant SBP75/LEDGF. The
antibody was then afﬁnity-puriﬁed using His-tagged rat
SBP75/LEDGF, and used at 0.05mg/ml in western blot
analyses.
Anti-GST (glutathione S-transferase) polyclonal anti-
body was raised in a rabbit against GST that was ex-
pressed in Escherichia coli. Afﬁnity-puriﬁed anti-GST
antibody was prepared using His-tagged GST, and used
at 0.07mg/ml in western blot analyses.
Rabbit polyclonal antibody to human histone H3
(trimethyl-K
4) (ChIP grade) and mouse monoclonal
antibody to bromodeoxyuridine (BrdU) Ab-3 (Clone
BRD.3) were purchased from Abcam (Cambridge, UK)
and Thermo Fisher Scientiﬁc (Fremont, USA), respect-
ively. Alexa 488-conjugated goat anti-human IgG and
Alexa 594-conjugated goat anti-rabbit IgG or goat
anti-mouse IgG were purchased from Invitrogen (USA).
Preparation of nuclear extract and fractionation of
supercoiled DNA-binding proteins
Nuclei were isolated from the brain of 2-week-old
Sprague-Dawley rats as described (29). To prepare
nuclear extract, nuclei were suspended at a ﬁnal concen-
tration of 5mg DNA/ml in an extraction buffer
containing 20mM Tris–HCl (pH 7.5), 0.3M NaCl,
140mM 2-mercaptoethanol, 50mg/ml bovine serum
albumin (BSA) and 0.2mM phenylmethylsulfonyl ﬂuoride
(PMSF) (30). For sodium dodecylsulfate-polyacrylamide
gel electrophoresis (SDS–PAGE), 7.5ml of the extract was
applied unless mentioned otherwise.
Ethidium bromide (EtBr) extract was prepared as
follows. Nuclei were suspended at a ﬁnal concentration
of 10mg DNA/ml in a buffer containing 10mM Tris–
HCl (pH 7.0), 5mM MgCl2, 2mM CaCl2,1 0 m M
dithiothreitol (DTT), 0.2mM PMSF and 20mM EtBr.
The suspension was incubated at 4 C for 30min and
centrifuged at 10000 g for 10min. The supernatant was
then loaded onto a Mono Q column (10/100 GL,
GE Healthcare) equilibrated with 20mM Tris–HCl
(pH 8.0) and 1mM DTT (buffer A). Proteins adsorbed
on the column were eluted with a linear gradient of
0–1M NaCl in buffer A. Fractions (1ml) were collected
and assayed for supercoiled DNA binding activity by
Southwestern blotting (described below). Binding acti-
vities associated with 75kDa (SBP75) and 48kDa
(SBP48) proteins were eluted between 0.2 and 0.3M
NaCl concentrations. Fractions containing these proteins
were combined separately and subjected to (NH4)2SO4
precipitation at 80% saturation. The resulting precipitate
was collected by centrifugation and solubilized in a
solution containing 20mM Tris–HCl (pH 7.5), 0.3M
NaCl and 1mM DTT (buffer B), and subjected to gel
ﬁltration chromatography on a Superose 12 column
(10/300 GL, GE Healthcare) equilibrated with buffer
B. Fractions (125ml) were collected and assayed for super-
coiled DNA binding activity by Southwestern blotting and
the peak fractions for SBP75 and SBP48 were pooled.
After concentration by ultraﬁltration with Microcon
ﬁlters (Millipore Corp.), samples were stored in 50%
glycerol at  20 C.
Cloning of cDNA for SBP75 protein
The cDNA of SBP75 protein was cloned by screening a rat
brain cDNA expression library (Uni-Zap XR, Stratagene)
with a human autoantibody against the SBP75. Brieﬂy, for
the primary screening  2.4 10
5plaques liftedonto 12 nitro-
cellulose ﬁlters (10 15cm), pretreated with isopropyl-thio-
b-D-galactopyranoside (IPTG), were incubated at 37 C
for 3h to induce the coded proteins. After blocking,
ﬁlters were incubated with 10mg/ml of human IgG (auto-
antibody against SBP75) that had been absorbed with
boiled E. coli. Washed ﬁlters were incubated with the
anti-human IgG conjugated with alkaline phosphatase
(Promega), which was then visualized with BCIP/NBT
Color Development Substrate (Promega). Six positive
plaques were recovered, ampliﬁed and plated again at
500 pfu/plate for the secondary screening. Three positive
clones were selected from each plate and tested for the
immunogenicity by immunoblotting before and after
IPTG induction. Nine clones selected from three individ-
ual plates produced the SBP75 protein-related proteins in
an IPTG-dependent manner. The SBP75 protein cDNAs
were recovered as pBluescript phagemid from the nine
phages according to the manufacturer’s instruction and
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ure on ABI 377 automatic sequencer (deposited in DDBJ,
accession #AB285525). Homologous sequences were
BLAST-searched on the NCBI website. Coding sequences
obtained were identical to that of rat LEDGF/p75/Psip1
(NM_175765).
To obtain a full-length cDNA of rat SBP75/LEDGF/
p75 (SBP75/LEDGF), the ORF of LEDGF/p75/Psip1
was ampliﬁed by PCR from rat brain cDNA expression
library (Uni-Zap XR, Stratagene) using primers contain-
ing the recognition sites for BamHI or EcoRI (listed in
Supplementary Table S1). The cDNA of Psip2 (rat
equivalent of human p52), a splice variant of rat
LEDGF/p75/Psip1, was also obtained by PCR from the
phage library with sense primer (50-GCGGATCCCAAAC
ATGACTCGCGATTTCA-30) and antisense primer
(50-GCGAATTCTGTAGTGTGTACCTTACA-30).
Construction of plasmids for protein expression
The multicloning sites of pFLAG-CMV-2 vector (Sigma-
Aldrich) and pCold II cold-shock expression vector
(Takara) were ﬁrst modiﬁed so as to accept any inserts
in frame that are excised out from the pGEX-3X expres-
sion constructs.
To obtain SBP75/LEDGF and its splice variant (rat
p52) that are fused with GST on N-terminus, PCR-
ampliﬁed cDNAs were digested with BamHI/EcoRI and
inserted between the corresponding sites of pGEX-3X
vector (GE Healthcare). For GST-fused deletion
mutants, DNA fragments were PCR-ampliﬁed from the
pGEX-3X full-length SBP75/LEDGF construct with the
primers listed in Supplementary Table S1 that contained
recognition sites for either BamHI or SmaI (sense
primers), or for EcoRI (antisense primers), and inserted
into pGEX-3X vector digested with appropriate enzymes.
GST-tagged C-terminal truncated proteins (1–336,
100–336, 200–336 and 268–336) were prepared by intro-
ducing a stop codon into the sequence that encodes K
337
of the pGEX-3X constructs for the N-terminal truncation
series (1–528, 100–528, 200–528 and 268–528). A site-
directed mutagenesis kit (QuikChange II, Stratagene)
was used with sense primer 50-AGAAGCCAGAAGTTA
AGTAAGTGGAGAAGAAGCGAGA-30, and antisense
primer 50-TCTCGCTTCTTCTCCACTTACTTAACTTC
TGGCTTCT-30, where underlined nucleotides were
altered to create the stop codon TAA.
To construct plasmids for GST-1–336
138–205, 1–336
134–276
and 1–336
200–276, the pGEX-3X construct containing
full-length SBP75/LEDGF with the stop codon at K
337
was PCR-ampliﬁed with KOD-Plus-DNA polymerase
(Toyobo Life Science) using sense primers positioned
downstream at the deletion and antisense primers
upstream, which contained SacII (for 138–205) or SalI
(for 134–276 and 200–276) overhangs. PCR products
were then digested with appropriate enzymes and
self-ligated to restore the uninterrupted coding frame as
designed.
For SBP75/LEDGF with hexa-histidine (His6) tagged
at N-terminus, PCR products were inserted between
BamHI and EcoRI sites of the modiﬁed pCold II. The
truncated protein (His-1–336) was prepared by intro-
ducing a stop codon at K
337 in the modiﬁed pCold
II-SBP75/LEDGF plasmid as described above.
To express FLAG-tagged proteins in mammalian cells,
coding sequences for GST-fusion proteins were PCR-
ampliﬁed and inserted into the BamHI/EcoRI sites of
the modiﬁed pFLAG-CMV-2.
For localization studies in living cells, we ﬁrst obtained
EGFP cDNA from pEGFP-N1 vector (Clontech) by
PCR ampliﬁcation using Phusion High-Fidelity DNA
Polymerase (Finnzymes) and a primer pair with HindIII
and BamHI overhangs. The EGFP cDNA was then
inserted into the multicloning site of modiﬁed pFLAG-
CMV-2 vector, which is preceded by FLAG. The resulting
plasmid (pFLAG-EGFP-CMV-2) was used as a vector for
expression of proteins fused with FLAG-eGFP on
N-terminus. Inserts used for the construction were PCR-
ampliﬁed from cDNA constructs either in pFLAG-
CMV-2 or pGEX-3X vectors. The FLAG-eGFP-fused
SBP75/LEDGF (1–528, 100–528 and 200–336) was
prepared by this scheme and the FLAG-eGFP-fused
internal deletion mutant (1–528
200–346) was constructed
by the inverse PCR/autoligation protocol as described
above for 1–336
134–276 and 1–336
200–276.
To obtain deletion mutants of SBP75/LEDGF fused
with eGFP on the C-terminus (93–336, 135–336,
167–336), DNA fragments were PCR-ampliﬁed with
primers containing restriction overhangs (EcoRI/BamHI)
from the full-length SBP75/LEDGF in pGEX-3X and
subcloned into pEGFP-N1 vector.
All the constructs used in this work were sequenced to
conﬁrm the absence of unintended mutations.
Expression and puriﬁcation of recombinant proteins
GST-fusion proteins were expressed in JM109 cells.
Bacterial pellets were sonicated in lysis buffer containing
150mM NaCl, 1mM EDTA, 0.5mM PMSF, 5mM DTT,
10mM Tris–HCl (pH 8.0) and 1mg/ml lysozyme. GST-
proteins were then puriﬁed using glutathione–Sepharose
4B (GE Healthcare) according to the manufacturer’s
instruction.
His-fusion proteins were expressed in BL21 cells
(Novagen) according to the manufacturer’s instruction.
Bacterial cells stored frozen were lysed in a buffer contain-
ing 300mM NaCl, 0.2mM PMSF, 10mM imidazole,
50mM NaH2PO4 (pH 8.0) and 1mg/ml lysozyme.
Sonicated lysates clariﬁed by centrifugation were injected
on to a HisTrap HP column (GE Healthcare). Bound
proteins were eluted with 300mM NaCl, 0.2mM PMSF,
250mM imidazole, and 50mM NaH2PO4 (pH 8.0).
To obtain FLAG-tagged SBP75/LEDGF, HEK 293 cells
grown to subconﬂuency on 100-mm dishes (2 10
6cells/dish)
were transfected with 3mg of the pFLAG-SBP75/LEDGF
plasmid using FuGENE 6 (Roche Molecular Biochemicals).
After 32h, cells were sonicated in a lysis buffer containing
420mM NaCl and the FLAG-tagged protein was afﬁnity-
puriﬁed on anti-FLAG M2 antibody-coated magnetic
beads, followed by elution with the 3 FLAG peptide
(Sigma) as described (31).
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mined by dye-binding assay kit (Bio-Rad) or densitomet-
ric scanning of CBB-stained gel bands using BSA as a
standard.
Southwestern blotting, western blotting and electrophoretic
mobility shift assay
DNA binding experiments with blotted proteins
(Southwestern blotting) was carried out as described
previously (29,32). Brieﬂy, proteins were separated by
SDS–PAGE and transferred electrophoretically onto a
polyvinylidene diﬂuoride (PVDF) membrane (Immobilon,
Millipore). When a multi-channel blotter was used, the
binding solution (200ml per slot) consisted of biotin-
labeled pUC18 DNA (0.1mg) and non-speciﬁc competitor
(100mg of calf thymus DNA and 60mg of yeast tRNA) in
the standard binding buffer containing 120mM KCl,
10mM MgCl2, 0.5mM DTT, 0.5mM EDTA, 250mg/ml
BSA, 0.2mM PMSF and 50mM Tris–HCl (pH 8.0). To
label DNA photochemically with biotin, form I (negative-
ly supercoiled), Ir (relaxed), or form III (linearized) DNA
of pUC18 was incubated with Photoprobe
R (long arm)
biotin (Vector Laboratories) under the conditions recom-
mended by supplier. The biotinylated DNA bound to
proteins was visualized by using alkaline phosphatase-
conjugated streptavidin and BCIP/NBT color develop-
ment substrate (Promega). When blotter was not used,
blotted membrane of mini-gel size was incubated in 2ml
of the standard binding buffer containing biotin-labeled
pUC18 DNA (1mg), calf thymus DNA (1mg), and yeast
tRNA (0.6mg).
Immunoblotting (western blotting) was carried out as
described (33). Protein-blotted membranes were incubated
with primary antibodies and then with peroxidase-
conjugated secondary antibodies (Bio-Rad) that were
visualized by either 4-methoxy-1-naphthol or ECL
TM
(GE Healthcare). Protein bands were recorded on
VersaDoc
TM imaging system (Bio-Rad) and quantiﬁed
by densitometry.
For electrophoretic mobility shift assay (EMSA),
puriﬁed proteins were incubated at 37 C for 30min with
0.1mg each of form I and III pUC18 DNA in 15mlo f
reaction mixture containing 35mM Tris–HCl (pH 8.0),
72mM KCl, 5mM MgCl2, 5mM DTT, 5mM spermidine,
50mg/mlBSAand5mgoflinearcalfthymusDNA.Samples
were then subjected to electrophoresis at 1.6V/cm on a 1%
SeaKem GTG agarose gel containing 10mM MgCl2 in
0.5 TBE (Tris–borate–EDTA) buffer. The tank buffer
(0.5 TBE) contained no MgCl2. After staining with
0.5mg/ml of EtBr, DNA bands were recorded on
VersaDoc
TM and quantiﬁed by densitometry.
Polypeptides of 27 amino acid residues (K9E9K9 and
K27) were synthesized (GenScript) and used in EMSA.
Oligonucleotides 50-ATG10C10G10AT-30,5 0-ATC10G10C10
AT-30,5 0-GCA10T10A10GC-30 and 50-GCT10A10T10GC-30
were also obtained (Sigma-Genosys) and the complemen-
tary pairs were annealed before use in EMSA.
To study the effects of chromomycin A3 and distamycin
A on supercoiled DNA binding, form I and III pUC18
DNA (0.1mg each) were preincubated with increasing
amounts of chromomycin A3 or distamycin A hydrochlor-
ide (Sigma-Aldrich) in the EMSA reaction mixture
for 5min at room temperature before adding either
5.2mg of GST-200-336 (protein/bp molar ratio of 0.4) or
62.5ng of polypeptides K9E9K9 /K 27 (peptide/bp molar
ratio of 0.063). Samples were then incubated for 30min at
37 C and separated on 1% SeaKem GTG agarose gel as
described above for EMSA procedure.
Cell transfection, Br-UTP incorporation and
immunoﬂuorescence microscopy
HeLa cells were grown on 13-mm round coverslips
immersed in Dulbecco’s modiﬁed Eagle’s medium
(DMEM) (Sigma-Aldrich) with 10% fetal calf serum.
Cells in subconﬂuency were transfected with FuGENE 6
and 1mg of the pFLAG-EGFP or pEGFP expression
vectors harboring full-length or mutant SBP75/LEDGF.
After 24h, live cells were examined under a microscope
equipped with epiﬂuorescence and ApoTome device
(Axiovert 200M, Carl Zeiss). Images were captured by a
cooled CCD camera (AxioCam MRm) using Axiovision
4.01 software (Zeiss). To observe eGFP signals in ﬁxed
cells, cells on coverslips were immersed in pure acetone
cooled to  80 C for 5h, and then incubated at  20 C
for 1h, 4 C for 20min and ﬁnally at room temperature
for 10min. After treating the cells with 0.75% paraform-
aldehyde in acetone at room temperature for 10min, cells
were immersed in phosphate-buffered saline (PBS,
150mM NaCl, 10mM sodium phosphate, pH 7.4) con-
taining 25% glycerol and 125mM glycine at room tem-
perature for 10min, and washed with 0.1M phosphate
buffer (pH 7.4). The ﬁxed cells were either examined
with the microscope, or subjected to immunolabeling.
To incorporate Br-UTP into permeabilized HeLa cells,
subconﬂuent cells on coverslips were treated for 3min at
room temperature with 0.05% Triton X-100 in glycerol
buffer containing 20mM Tris–HCl (pH 7.4), 5mM
MgCl2, 25% glycerol, 0.5mM PMSF and 0.5mM
EGTA. Permeabilized cells were incubated for 10min at
room temperature with 0.5mM each of ATP, CTP, GTP
and 0.2mM Br-UTP (Sigma-Aldrich) in transcription
buffer containing 100mM KCl, 50mM Tris–HCl
(pH 7.4), 5mM MgCl2, 0.5mM EGTA, 25% glycerol,
25mM S-adenosyl-L-methionine, 5U/ml placental RNase
inhibitor and 1mM PMSF (34). Cells were washed with
ice-cold TBS (150mM NaCl, 5mM MgCl2, 10mM Tris–
HCl, pH 7.4) containing 0.5% Triton X-100 and 5U/ml
RNase inhibitor and then ﬁxed with freshly made 4%
paraformaldehyde in 0.1M phosphate buffer (pH 7.4),
followed by immunolabeling.
For immunoﬂuorescence microscopy, subconﬂuent
HeLa cells on glass coverslips were ﬁxed with 4% para-
formaldehyde, permeabilized with 0.3% Triton X-100 in
PBS, and blocked with 10% goat serum and 10% horse
serum in PBS containing 0.3% Triton X-100 (TPBS).
After incubation with primary antibodies diluted in
TPBS containing 1% goat serum, sections were washed
with PBS, followed by incubation with ﬂuorescent con-
jugates of goat secondary antibodies in PBS (33,35).
Cells were ﬁnally stained for DNA with 0.25mg/ml
5070 Nucleic Acids Research, 2011,Vol.39, No. 1240,6-diamidino-2-phenylindole (DAPI) in PBS and
examined under the microscope.
RESULTS
Identity of SBP75 as LEDGF/p75
In a previous study, we detected DNA binding activities
selective for supercoiled DNA in the nuclear fraction
isolated from rat brain (29). To ﬁnd out responsible
factors for the activity, proteins were extracted from
puriﬁed nuclei and subjected to Southwestern blotting
analysis using pUC18 DNA labeled with biotin, either
negatively supercoiled (I) or linearized (III) forms, as
probes (Figure 1A). Three protein bands (75K, 120K
and 180K) were detected with biotin-labeled probes
(lanes 2 and 4). Unlabeled non-speciﬁc competitors, a
mixture of calf thymus DNA fragments and yeast
tRNA, replaced the binding of form III probe to all
proteins (lane 3), whereas the competitor failed to
replace the binding of form I probe to 75K and 180K
proteins (lane 5). Additional unlabeled competitors,
form III or form Ir (relaxed from I), also failed to
replace the binding of supercoiled DNA probe (lanes
6–9). However, the binding was effectively abolished by
unlabeled form I DNA (lanes 10 and 11), indicating that
75K and 180K proteins preferentially recognize super-
coiled DNA (see also Supplementary Figure S2 for more
evidence).
Since some DNA binding proteins that recognize DNA
superstructures are selectively released from chromatin by
DNA-intercalating agents such as EtBr (36), we tried to
enrich these proteins by treating isolated nuclei with EtBr.
As shown in Figure 1B, the EtBr extract contained
proteins with apparent molecular mass of 75 and 48kDa
that showed preferential binding to supercoiled DNA.
These proteins will be referred to as SBP75 and SBP48
hereafter (SBP stands for supercoiled DNA binding
protein). The 180K polypeptide was not detected in the
EtBr extract. The release of SBP75/48 was solely depend-
ent on EtBr treatment since both proteins were not ex-
tracted without EtBr (data not shown). The EtBr extract
was then subjected to an anion exchange chromatography
(Mono Q), followed by gel ﬁltration (Superose). The left
and the middle panels of Figure 1C show that SBP75 and
SBP48 were eluted together from Mono Q column at
0.2–0.3M NaCl, and separated by gel ﬁltration into
SBP75-enriched (Superose 75K) and SBP48-enriched
(Superose 48K) fractions.
In an attempt to obtain autoantibodies to nuclear
proteins, we found a highly speciﬁc antibody to SBP75 in
a patient serum with Miller–Fisher syndrome (Figure 1C,
right panel). The syndrome is characterized as an acute
autoimmune-mediated neuropathy with serum antibodies
to gangliosides such as GQ1b, GM1 and GD1a (37). It is
worth noting that Miller–Fisher syndrome sometimes
occurs early in HIV infection before AIDS develops (38).
SBP48 was not recognized by the autoantibody. Using this
antibody, we screened a rat brain phagemid library for
cDNA expression. Six positive clones were obtained from
2.4 10
5 plaques. After secondary screening, three positive
plasmid clones were recovered and sequenced. The over-
lapping sequences spanning 2979nt contained a coding
sequence identical to that of rat LEDGF/p75/Psip1
(NM_175765). The resulting sequence extended further
downstream, terminating at an alternative poly(A) site
(deposited in DDBJ as AB285525).
Rat SBP75/LEDGF/p75 (SBP75/LEDGF) expressed as
GST-fused or FLAG-tagged proteins were recognized by
the human autoantibody as expected (Figure 1D). An al-
ternatively spliced variant of p75 is expressed as p52, which
shares N-terminal 325 (323 in rat) residues of p75 (3). The
coding sequence of rat p52 (BC093606) was ampliﬁed from
the rat cDNA library and expressed as a GST-fused
protein, which failed to react with human autoantibody.
Reactivity of this antibody against a series of GST-fused
SBP75/LEDGF deletion mutants showed that the
antibody epitope resides within the C-terminal region
(amino acids 386–528) (Supplementary Figure S1). A poly-
clonal antibody raised against the N-terminal region
(amino acids 1–197) of rat SBP75/LEDGF recognized
GST-SBP75/LEDGF and GST-rat p52, as well as 75 and
48kDa proteins in the nuclear extract, indicating that
SBP75 is indeed the rat LEDGF/p75 and that SBP48 is
equivalent to the recombinant rat p52. Southwestern
blotting analysis of FLAG- and His-SBP75/LEDGF
conﬁrmed the preferential binding of expressed proteins
to supercoiled DNA (Figure 1E and Supplementary
Figure S2A).GST-taggedSBP48/p52alsoshowed thepref-
erence to supercoiled DNA on Southwestern blotting
(Supplementary Figure S3).
The binding of SBP75/LEDGF to supercoiled DNA
was further analyzed by gel retardation assay (Figure 2).
We used here either His-tagged SBP75/LEDGF (His-528)
or a C-terminal truncation mutant (His-336), which
is nearly identical to SBP48/p52. As illustrated in
Figure 2A, His-336 contains all the domains involved in
chromatin tethering, PWWP (23) and DNA binding, NLS
and AT-hooks (22). Both proteins bound to both DNA
forms (forms I and III) in the absence of competitor
DNA, but in its presence they bound selectively to super-
coiled DNA, as only form I DNA retarded signiﬁcantly at
the protein-to-base pair molar ratio of higher than 0.02
(Figure 2B). Levels of afﬁnity to DNA were comparable
between His-528 and His-336. The supercoil-speciﬁc band
shift was not observed when Mg
2+ ion was removed from
the gel buffer (data not shown). These results indicate
that the N-terminal portion of SBP75/LEDGF (1–336)
is sufﬁcient for the supercoil-speciﬁc DNA binding and
the C-terminal region including the IBD is dispensable.
Identiﬁcation of the recognition domain for
supercoiled DNA
To locate a responsible region for the supercoil speciﬁ-
city in the protein, GST-tagged N-terminal fragment
(GST-1–336) and its deletion mutants were analyzed by
Southwestern blotting (Figure 3A). Deleting amino acids
275–336 from GST-1–336 (GST-1–274) resulted in a
drastic decrease of supercoiled DNA binding activity to
one-third (Figure 3B and C). GST-1–206 that contains
NLS and two AT-hook motifs, known elements
Nucleic Acids Research, 2011,Vol.39, No. 12 5071responsible for the protein’s DNA binding ability (22), did
bind pUC18 DNA but without any preference to super-
coiled conformation. GST-1–137 harboring PWWP
domain did not bind neither form I nor form III DNAs
(Figure 3B). Conversely, a mutant without PWWP
domain (GST-100–336) retained the supercoil speciﬁcity
(Figure 3B) although the activity reduced to almost one
half (Figure 3C). To our surprise, further deletion of the
canonical DNA binding domain (NLS and AT-hooks, aa
148–196) did not abolish DNA binding activity of the
protein nor preference to supercoiled DNA. The super-
coiled DNA binding activity of GST-200–336 was
comparable to that of GST-100–336 (Figure 3B and C).
We found that GST-268–336, the C-terminal half of the
GST-200–336, does not show any DNA binding activity
(Figure 3B), and that the N-terminal half (GST-200–274)
is sufﬁcient to recognize and bind supercoiled DNA
(Figure 3B). Although the binding activity of GST-200–
274 detected in Southwestern blotting was very low, the
essential role of this region in recognizing supercoiled
DNA was conﬁrmed by the failure of GST-1–336
mutant that lacks aa 200–276 (200–276) to recognize
supercoiled DNA (Figure 3B and C). Therefore, the
amino acids 200–274 region seems to be the primary site
Figure 1. Supercoiled DNA-binding protein SBP75 is identical to LEDGF/p75. (A) Detection of DNA binding proteins in rat brain nuclear extract
by Southwestern blotting. Nuclear extract (75ml) was subjected to 7.5% SDS–PAGE and separated proteins were blotted on a membrane, which was
then incubated with biotin-labeled pUC18 DNA: form III (lanes 2 and 3) or form I (lanes 4–11) in the absence (lanes 2 and 4) or the presence (lanes
3 and 5–11) of non-speciﬁc competitors (calf thymus DNA and yeast tRNA). Excess amounts of unlabeled pUC18 DNA: form III (lanes 6 and 7),
form Ir (lanes 8 and 9) or form I (lanes 10 and 11) were added at 5-fold (lanes 6, 8 and 10) or 25-fold excess (lanes 7, 9 and 11). Proteins with
apparent molecular mass of 180kDa (180K), 120kDa (120K) and 75kDa (75K) are indicated. Total protein on the membrane was stained with CBB
(lane 1). (B) Proteins extracted with 20mM EtBr were subjected to Southwestern blotting (SWB). The blot was incubated with biotin-labeled form I
pUC18 in the presence of non-speciﬁc competitors. Supercoiled DNA bound to the two proteins labeled SBP75 and SBP48 selectively (right lane).
Total protein in the extract was stained with CBB (left lane). (C) Proteins in 20mM EtBr extract were fractionated by chromatography on Mono Q
and Superose columns and pooled fractions were subjected to SDS–PAGE and stained with silver reagent (left panel). The same sets of samples were
blotted onto a membrane and analyzed by SWB or western blotting (WB) with human autoantibody to SBP75. (D) Rat nuclear extract and SBP75
recombinant proteins were subjected to western blotting analysis with human autoantibody to SBP75 (Human Ab, lanes 1–4) or with newly prepared
anti-rat SBP75/LEDGF polyclonal antibody (SBP75 Ab, lanes 5–8). Open arrows indicate endogenous SBP75 and closed arrow indicates SBP48 that
was reactive to polyclonal antibody but not to human autoantibody. Lower bands in GST fusion proteins that were detected by SBP75 Ab (indicated
by asterisk in lanes 6 and 7) but not by human Ab are degradation products lacking C-terminal portions. For further analysis of epitope position
recognized by human autoantibody, see Supplementary Figure S1. (E) Puriﬁed FLAG- or His-tagged SBP75/LEDGF (2.5mg each) was subjected to
Southwestern analysis as in panel A. CBB-stained proteins are shown in the left most lane.
5072 Nucleic Acids Research, 2011,Vol.39, No. 12for the interaction with supercoiled DNA (thus called
‘core’) and the contiguous C-terminal region (up to
amino acid 336) appears to enhance the interaction
(called ‘enhancer’).
Now we term the amino acids 200–336 region as SRD
(illustrated in Figure 4A). The conventional DNA binding
region expressed as a GST-fusion protein (GST-137–206)
bound pUC18 DNA without any preference to DNA
superstructure (Figure 3B). Deletion of this region
(138–205) did not abolish the preferential binding to
supercoiled DNA (Figure 3B and C), suggesting that this
domain is dispensable for the supercoiled DNA-binding
activity. Therefore, the amino acids 137–206 region is
termed as NRD that designates non-speciﬁc DNA-
recognition domain (Figure 4A). As expected, deletion of
both NRD and the core region of SRD (134–276) abol-
ished the conformation-speciﬁc as well as non-speciﬁc
DNA binding activities (Figure 3B and C). It is clear now
that SBP75/LEDGF contains two discrete DNA binding
domains, one that binds DNA without preference to DNA
superstructure (NRD) and the other that binds supercoiled
DNA selectively (SRD).
SRD (amino acids 200–336) and NRD (amino acids
137–206) were further analyzed by EMSA (Figure 4A,
lower panels). GST-137–206 (NRD) bound to both
linear (form III) and supercoiled (form I) DNAs at a
molar ratio of >0.01 as revealed by the dose-dependent
band shift, which was cancelled completely by the linear
competitor DNA. The result corroborates the non-speciﬁc
nature of the DNA binding to NRD. In contrast,
GST-200–336 (SRD) showed a preferential binding
to form I DNA both in the presence and absence of
calf thymus DNA at the molar ratio of higher than 0.4.
The SRD core (GST-200–274) also showed a prefer-
ence to supercoiled DNA at the molar ratio of >1.0.
Although the relative binding activity of SRD core was
Figure 3. Nailing down the region of SBP75/LEDGF that is respon-
sible for supercoiled DNA binding activity by Southwestern blotting.
(A) Deletion mutants of GST-SBP75/LEDGF used for the analysis are
illustrated. Domain structure of N-terminal fragment (amino acids 1–
336) is shown on the top. (B) Protein amounts loaded to the gel were
either 5mg (indicated by asterisks on the left) or 1.5mg (others). Blotted
membranes were incubated with biotin-labeled pUC18 as in Figure 1A.
DNA binding to linear DNA or preferential binding to supercoiled
DNA is summarized on the right. (C) Relative binding activity of
SBP75/LEDGF deletion mutants. GST-fusion proteins (50ng each,
except GST-1–206 and GST-200–336 that were100 ng) were loaded to
7.5% polyacrylamide gel. Binding of biotin-labeled pUC18 form I
DNA in the presence of non-speciﬁc competitors was measured by
scanning densitometry. To express the binding activity on a molar
basis with respect to proteins, an identical blot was probed with
afﬁnity-puriﬁed anti-GST polyclonal antibody and the quantiﬁed
band intensities were used to normalize the DNA binding. Data
shown are relative values to GST-1–336 (average for three independent
experiments with error bars).
Figure 2. Preferential binding of recombinant proteins to supercoiled
DNA can be detected by gel shift assay (EMSA). (A) The domain
structure of rat SBP75/LEDGF variants and His-tagged proteins used
in the binding assay. Numbers on top are amino acid residue numbers.
PWWP domain, nuclear localization signal (NLS), double AT-hook
motif and IBD (integrase-binding domain) are indicated. Rat SBP48/
p52 shares amino acids 1–323 with SBP75/LEDGF (thick solid line)
and the following eight residues are unique (hollow line). (B) Gel re-
tardation patterns of pUC18 plasmid DNA (forms I and III) with
His-528 or His-336 in the absence (left panel) or in the presence
(right panel) of calf thymus DNA fragments (CT-DNA). The protein
amounts added were expressed as protein-to-nucleotide (bp) molar
ratio: 0 (lanes 1 and 7), 0.01 (lanes 2 and 8), 0.02 (lanes 3 and 9),
0.03 (lanes 4 and 10), 0.04 (lanes 5 and 11) and 0.05 (lanes 6 and 12).
Nucleic Acids Research, 2011,Vol.39, No. 12 5073signiﬁcantly lower than that of SRD, the core consisting of
75 amino acids can be regarded as the minimal domain for
supercoil recognition. The absence of any DNA binding
activity associated with GST- 268–336 (Figure 4A) is con-
sistent with the result of Southwestern blotting
(Figure 3B), although the region enhanced the binding
of supercoiled DNA by SRD core >2-fold when attached
to it. Interestingly, the core and the enhancer portion of
SRD roughly correspond to the charged region 2 (CR2)
and the charged region 3–4 (CR3–4), respectively, that
were reported in previous studies (23,39).
Prediction of higher order structure in silico revealed
that the highly charged SRD is a disordered region with
little folded structure (Supplementary Figure S4). The core
region of SRD does not contain any known DNA-binding
motifs, as well. To identify sequence motifs responsible for
the recognition of DNA superstructure, SBP75/LEDGF
amino acid sequences from 13 different species that are
homologous to SRD were aligned (Supplementary
Figure S5A). The region was enriched with lysine (K)
and glutamic acid (E) residues that were highly conserved
among these species (Supplementary Figure S5B).
Although acidic residues, E and D, are generally used
sparingly in DNA binding, both have similar preferences
for amino acid–base pair hydrogen bonding (40). When E
and D were considered to be equivalent, 22 out of 26
acidic residues of rat SRD are conserved. The sequence
logo representation of SRD showed that conserved lysines
are more or less clustered into several groups and acidic
stretches composed of conserved E and D intervene
the lysine clusters in SRD (Figure 4B). Five lysine
clusters (K1–K5) and four acidic clusters (E/D1–E/D4)
were recognizable in SRD when the criteria for being a
cluster was more than three consecutive residues of K
or E/D allowing the interruption by up to three unrelated
residues. Four out of ﬁve lysine clusters were located
in the core, K2 and K3 ﬂanking E/D2 at the center
to form a characteristic stretch of 27 amino acids
composed of nine residues each of basic–acidic–basic
conﬁguration (Figure 4B).
To study whether these 27 amino acids (K2–E/D2–K3)
of the core region play primary roles in the preferential
binding to supercoiled DNA, we synthesized oligopeptides
that mimic this stretch and used in EMSA. As expected,
polypeptide K9E9K9 preferentially bound to form I DNA
at the peptide/base pair molar ratio of 0.063, about six
times smaller ratio than that observed with GST-200–
336. Since polypeptide K27 bound to both forms of
DNA at the same molar ratio without showing any pref-
erence toward form I DNA, not just basic lysine stretch
but alternating clusters of K–E–K are required to prefer-
entially recognize supercoiled DNA (Figure 4C). A statis-
tical analysis of protein–DNA contacts revealed that
lysine residue can form stable hydrogen bonds with
guanine base in the major groove (40). Similarly,
glutamic or aspartic acid residues interact frequently
with cytosine base. These facts suggest that the K–E–K
cluster in SRD core may interact preferentially with DNA
containing a G–C–G cluster. By assuming that the con-
formation of K9E9K9 is an extended random coil and it
may interact with three helical turns of DNA, we
synthesized a double-stranded oligonucleotide represent-
ing a G–C–G cluster (G10C10G10). When this oligonucleo-
tide was added to the EMSA reaction with SRD
(GST-200–336) and supercoiled DNA, the supercoil-
speciﬁc band shift was abolished by competition in a
dose-dependent manner, whereas the control oligonucleo-
tide A10T10A10 did not show any competition (Figure 4D).
Involvement of K2–E/D2–K3 region of SRD in super-
coiled DNA recognition was further suggested by EMSA
experiments using DNA-interacting agents with certain
base preferences (chromomycin A3 and distamycin A).
Chromomycin A3 that binds double-stranded DNA with
GC base pair speciﬁcity counteracted the shift of super-
coiled DNA by either GST-200–336 or polypeptide
K9E9K9 in a dose-dependent manner. Whereas, dis-
tamycin A that has AT base pair speciﬁcity showed no
effect on the shift (Supplementary Figure S6A and B).
Also, both agents had no effect on the binding of K27
with form I and III DNAs at the same peptide-to-base
pair molar ratio (Supplementary Figure S6B). These
results are perfectly complementary to the data shown in
Figure 4C and D. Taken together, the alternating clusters
of K and E/D in the SRD core are likely to be involved in
the preferential binding of SBP75/LEDGF to some
GC-rich segments in supercoiled DNA (see ‘Discussion’
section for more detail).
Colocalization of SBP75/LEDGF with active
transcription sites in the nucleus
Negative supercoils generated at transcription sites were
shown to propagate through chromatin ﬁber in vivo (28).
Proteins capable of recognizing supercoils would be
concentrated in a close proximity of actively transcribed
chromatin regions. Intranuclear distribution of endogen-
ous SBP75/LEDGF was studied in relation to transcrip-
tion sites that are highlighted by immunopositive area
detected with a speciﬁc antibody against trimethyl-lys
4
of histone H3 (H3K4me3). Unexpectedly, overall distribu-
tion of endogenous SBP75/LEDGF and H3K4me3 as de-
tected by double immunostaining appeared to be mutually
exclusive: SBP75/LEDGF signals tend to overlap with
condensed chromatin area whereas H3K4me3 signals
were observed in dispersed chromatin (Figure 5A, upper
panels). However, magniﬁed images of the H3K4me3
immunopositive area revealed a speckled distribution
of SBP75/LEDGF overlapping with or juxtaposed to
H3K4me3-positive area in inter-chromatin space
(Figure 5A, arrows in lower panels). Additional data are
shown in Supplementary Figure S7A. Sites of ongoing
transcription in the nucleus (transcription foci) were
visualized more directly by incorporation of Br-UTP
(Figure 5B, upper panels). Closer observation at a higher
magniﬁcation showed that Br-UTP signals distribute in a
punctuated pattern in the area of relative DNA depletion,
partially overlapping with or locating close to SBP75/
LEDGF signals (Figure 5B, arrowheads in lower panels).
Additional data are shown in Supplementary Figure S7B.
Thus, a part of endogenous SBP75/LEDGF appears to
colocalize with transcriptionally active regions in the
nucleus.
5074 Nucleic Acids Research, 2011,Vol.39, No. 12Figure 4. Further characterization of DNA-binding domains of SBP75/LEDGF. (A) Subregions of the central portion (137–336) were expressed as
GST-fusion proteins and their DNA binding properties were analyzed by EMSA. Domain structure of SBP75/LEDGF is illustrated on the top,
including the charged region (CR1–4) and newly identiﬁed DNA-binding domains: non-speciﬁc DNA-recognition domain (NRD) and supercoiled
DNA-recognition domain (SRD). GST-fused fragments used in the assay are shown beneath. Numbers indicate the residue number of SBP75/
LEDGF. Shown in the lower panels are mobility shift patterns of supercoiled (I) and linear (III) DNA for each protein. Increasing amounts of
GST-fused proteins were incubated with DNA in the absence ( ) or presence (+) of CT-DNA. Prot/bp stands for the molar ratio of protein/base
pare of DNA. (B) Visual assessment of essential elements in SRD by using sequence logo representation. The minimal element for supercoiled DNA
binding (core) and a region that enhances the supercoil-speciﬁc binding (enhancer) are indicated on the top. Homologous regions of 13 species were
aligned (Supplementary Figure S5A), and each amino acid residue was scaled by the total bits of information multiplied by the relative occurrence of
the amino acid residue at the position. Attached residue numbers are for rat SBP75/LEDGF. Red bars indicate acidic clusters (E/D1–E/D4) and blue
bars indicate lysine clusters (K1–K5). For cluster deﬁnition see in the text. (C) EMSA analysis of a polypeptide K9E9K9 that mimics the cluster
structure of the core (K2–E/D2–K3). Increasing amounts of K9E9K9 or K27 (control) were incubated with forms I and III pUC18 DNA. In this
experiment, actual amount of added polypeptide was 0.5mg per reaction at the polypeptide/base pair molar ratio (peptide/bp) of 0.5. (D) Competitive
effects of double-stranded oligonucleotides G10C10G10 and A10T10A10 on the binding of supercoiled DNA with SRD. Increasing amounts of the
oligonucleotides indicated on top were added into the reaction mixture containing 6.5mg of GST-200–336 (equivalent to 0.5 protein/bp) (left panel).
Band densities of form I DNA relative to that of DNA alone (S) are plotted (right panel).
Nucleic Acids Research, 2011,Vol.39, No. 12 5075We next examined whether or not SRD, the newly iden-
tiﬁed supercoiled DNA binding domain, is a primary
determinant for the association of SBP75/LEDGF with
transcription sites by using eGFP-fused rat proteins ex-
pressed in HeLa cells (Figure 6A). To identify artifacts
originating from ﬁxation, cell images were taken under
different conditions of ﬁxation and compared with live
cell images (Figure 6B). The wild-type SBP75/LEDGF
(aa 1–528) observed in live cells showed intranuclear
speckled distribution excluded from nucleoli, which is
similar to the pattern of human LEDGF/p75 expressed
in CHO-K1 cells (41) or HeLa cells (6). Intranuclear dis-
tribution of the protein had been shown to be almost co-
incident with DNA (5,9,22). Despite the absence of NLS,
SRD (eGFP-200–336) localized exclusively in nuclei
like the wild-type protein (Figure 6B, left column).
When cells were ﬁxed with a standard ﬁxative (4% para-
formaldehyde), however, SRD changed its intranuclear
distribution drastically to apparent association with the
nucleolus-like structure that was rather avoided by the
protein in live cells (Figure 6B, middle column). This re-
location phenomenon was not evident with the wild-type
protein. It is very likely to be caused by the absence of
PWWP domain, since all the SBP75/LEDGF mutants
lacking this domain showed similar relocation when
ﬁxed with paraformaldehyde (Supplementary Figure S8).
We found that this artifact can be prevented by treating
the cells with acetone at  80 C prior to the paraform-
aldehyde ﬁxation (Figure 6B, right column). The cold-
acetone pre-treatment did not affect the localization of
Figure 5. Intranuclear distribution of endogenous SBP75/LEDGF and active transcription sites in HeLa cells. (A) Cells were ﬁxed with 4%
paraformaldehyde and immunostained doubly with afﬁnity puriﬁed human autoantibody to SBP75/LEDGF (3mg/ml) and rabbit polyclonal
antibody to human trimethyl-lysin
4 in histone H3 (H3K4me3, 1/1000 ), followed by incubation with Alexa 488-conjugated goat anti-human IgG
(5mg/ml) and Alexa 594-conjugated goat anti-rabbit IgG (5mg/ml). DNA was stained with DAPI (0.25mg/ml). Boxed area in upper panels was
magniﬁed and shown in lower panels. Arrows in the area with weak DAPI signal indicate that Alexa 488 (green) and Alexa 594 (magenta) signals are
overlapped or juxtaposed in the merged image. Scale bars designate 5mm (upper panels) and 1mm (lower panels), respectively. (B) Br-UTP was
incorporated into transcription sites in the cells permeabilized with 0.05% Triton X-100 by incubation with other nucleotides and detected with
anti-BrdU mouse monoclonal antibody (1mg/ml) that was visualized with Alexa 594-labeled second antibody. Endogenous SBP75/LEDGF was also
detected with afﬁnity puriﬁed human autoantibody to SBP75/LEDGF as in panel A. Arrowheads in low DAPI area indicate that Alexa 488 (green)
and Alexa 594 (magenta) signals were overlapped or juxtaposed in the merged image. Scale bars designate 2mm (upper panels) and 0.5mm (lower
panels), respectively.
5076 Nucleic Acids Research, 2011,Vol.39, No. 12Figure 6. Analysis of domain function for intranuclear localization: eGFP-fused SBP75/LEDGF deletion mutants expressed in HeLa cells.
(A) Schematic representation of eGFP-fused proteins in relation to domains of rat SBP75/LEDGF, PWWP and SRD. Amino acid residue
numbers are indicated. (B) Effects of ﬁxation conditions. eGFP-SBP75/LEDGF (1–528), eGFP-SRD (200–336) or eGFP (control) were transiently
expressed in HeLa cells, and eGFP signal was detected in live cells (left panels), in cells ﬁxed with 4% paraformaldehyde (middle panels), and in cells
pretreated with cold acetone before ﬁxation with 0.75% paraformaldehyde (right panels). Scale bars, 5mm. (C–F) Distribution of transcription sites
(H3K4me3) in relation to locations of eGFP-fused SBP75/LEDGF deletion mutants expressed in HeLa cells. Cells were treated with cold acetone
prior to ﬁxation with paraformaldehyde. The ﬁxed cells were immunolabeled with anti-H3K4me3 antibody (1/1000 ) and Alexa 594-conjugated goat
anti-rabbit IgG (5mg/ml). eGFP was visualized directly as ﬂuorescence. Boxed area in upper panels of (C) and (D) was magniﬁed and shown in lower
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(Continued)full-length SBP75/LEDGF. In the following experiments,
therefore, cells were pretreated with cold acetone before
aldehyde ﬁxation.
Being consistent with the results of endogenous SBP75/
LEDGF, general distribution of eGFP-SBP75/LEDGF
and H3K4me3 were mutually exclusive (Figure 6C, upper
panels). Like the endogenous protein, a portion of eGFP-
SBP75/LEDGF colocalized with H3K4me3 in dispersed
DNA area as shown in the enlarged images (Figure 6C,
yellow circles in lower panels). In these images, the signal
intensity of GFP overlapping with DAPI was reduced
by digital subtraction (GFP-DAPI) to highlight the
protein distributed in dispersed chromatin. Deletion of
SRD from the SBP75/LEDGF (eGFP-200–346) did not
apparently changed the overall distribution of the protein,
most of the signals being excluded from H3K4me3 signals
(Figure 6D, upper panels). When observed more closely,
however, the SRD-deleted protein was absent from the
H3K4me3 positive region and rather present in DNA-
rich area (Figure 6D, yellow circles in lower panels),
which is clearly different from the situation with the
wild-type protein (Figure 6C, lower panels). These obser-
vations are supported by additional data shown in
Supplementary Figure S9. The results suggest that SRD
is indeed a primary determinant for targeting the protein
to transcription sites.
Then, why does most of SBP75/LEDGF locate in con-
densed chromatin regions regardless of SRD presence?
The N-terminal PWWP domain was shown to play a
dominant role in tethering the protein to chromatin
(22,23,42). Therefore, we expressed a PWWP deletion mu-
tant (eGFP-100–528) in HeLa cells and eGFP signals were
looked at in relation to H3K4me3 signals. As expected,
the deletion mutant lost the ability to colocalize with
condensed chromatin and distributed diffusely in both
H3K4me3-positive and negative regions (Figure 6E).
Finally, we assessed the localization of SRD (eGFP-200–
336) that lacks both PWWP and NRD. Distribution of
this construct correlated well with that of H3K4me3
signals and rather excluded from condensed chromatin
regions as shown more clearly by the densitometric
proﬁles (Figure 6F). These results suggest that nuclear
SBP75/LEDGF is mainly tethered to chromatin through
the PWWP domain but a small portion of the protein is
recruited to transcriptionally active region by SRD that
recognizes negative supercoils generated at transcription
sites (illustrated in Figure 7).
DISCUSSION
We show here for the ﬁrst time that LEDGF/p75, a
protein known to interact with HIV-1 integrase and
plays an important role in the targeting of viral genome
to host DNA, recognizes and binds negatively supercoiled
DNA preferentially. We had been characterizing this
protein for some time as a supercoiled DNA binding
protein with apparent molecular mass of 75kDa (thus
termed SBP75). Canonical DNA binding domain of
LEDGF/p75 was mapped to residues #93–226 harboring
NLS (amino acids 148–156) and two AT-hook motifs
(amino acids 177–196) (22). We conﬁrmed that the
tagged-fragment of aa137–206 containing NLS and
AT-hooks bound to DNA in vitro. However, this region
did not show any preference to supercoiled DNA. We
found instead that a novel domain spanning residues
#200–336 was capable of binding to DNA with preference
to supercoils. Thus, amino acids 137–206 region was
termed as NRD and the region of amino acids 200–336
as SRD.
The SRD does not contain any known motif for DNA
binding but this domain is highly conserved among species
and had been referred to as ‘charged regions’ in human
LEDGF/p75 (23,39). Previous studies indicated that
although the charged regions were not necessary for chro-
matin tethering of LEDGF/p75, CR2 (amino acids
198–266, amino acids 197–265 in rat sequence) did show
Figure 6. Continued
panels. In the panels designated ‘GFP-DAPI’, DAPI signal was subtracted pixel-by-pixel from the eGFP signal and the remaining signal is shown
here after background subtraction (see Supplementary Figure S9 for detailed description). The region is outlined by yellow circles in other panels for
reference. In panels E and F, relative signal intensities were scanned along the yellow lines drawn and plotted in the graphs shown on the bottom. All
the merged images were made from SBP75/LEDGF (green) and H3K4me3 (magenta). Scale bars designate 5mm except in the magniﬁed images in
panels C and D, which represent 1mm.
Figure 7. A model for domain-guided localization of SBP75/LEDGF
in nuclear compartments. Three domains in SBP75/LEDGF (PWWP,
NRD and SRD) are likely to be involved in the localization. PWWP
exerts a strong tethering effect that directs the protein, for the most
part, to condensed chromatin territory, probably through interaction
with nucleosomes. NRD may bind to any DNA in a structure-
independent manner, whereas SRD binds selectively to negative super-
coils generated around the transcription factory, thus recruiting IBD-
bound proteins (data not shown) for preferential targeting toward
active transcription units. Although it is not indicated in the scheme,
PWWP in the targeted complex may also interact with nearby
nucleosomes.
5078 Nucleic Acids Research, 2011,Vol.39, No. 12some contribution to chromatin binding (23,39), which
may reﬂect our ﬁnding that SRD core (amino acids
200–274) possesses a weak but supercoil-speciﬁc DNA
binding ability. The C-terminal end of SRD core contains
an evolutionally conserved serine cluster (residues 270, 272
and 274) that was reported to be involved in HIV-1 DNA
integration, although mutations of these serine residues to
alanine did not alter chromatin binding, nor integrase-to-
chromatin-tethering capability of LEDGF/p75 (39).
The core region of SRD has a characteristic feature of
alternating clusters of acidic (E/D) and basic (K) amino
acids that are evolutionally conserved (Figure 4B). The
basic–acidic–basic cluster in the center (K2–E/D2–K3)
was suggested to be a primary element for the recognition
and binding of supercoiled DNA since a polypeptide
K9E9K9 that mimics the cluster showed a DNA binding
activity as potent as GST-SRD. Furthermore, a duplex
oligonucleotide G10C10G10 was inferred to be an effective
binder of K9E9K9 when interactions through hydrogen
bonding in the major groove were postulated (40). As
expected, G10C10G10 duplex interfered with the preferen-
tial binding of GST-SRD to supercoiled DNA.
Involvement of clustered lysine residues in supercoiled
DNA binding was suggested previously (43,44). A
lysine-rich sequence (TKKKFKD) associated with the B
domain of HMG-1 was a prerequisite for supercoiled
DNA binding (43). Also, lysine residues immobilized on
sepharose beads through the a-amino group was shown to
recognize supercoiled plasmid DNA speciﬁcally and thus
could be used as an afﬁnity matrix to remove linear DNA
(44). The basic lysine stretch in SRD, however, was not
the only element for supercoiled DNA recognition because
the polypeptide K27 did not show any preference to DNA
superstructure. The acidic residues ﬂanked by lysine
clusters seem to play an important role in the recognitions
of supercoils although acidic amino acid side chains are
rather avoided in DNA binding domains, presumably
because of unfavorable electrostatic interactions between
the side chains and phosphate groups of DNA. In one
report, however, glutamic acid/aspartic acid clusters in
chromatin protein Sin1p/Spt2p were shown to bind super-
coiled DNA in a preferential manner (45).
In linear form duplex DNA whose ends are uncon-
strained, GC-rich tetranucleotide segments show a strong
tendency to have wider minor groove than AT-rich coun-
terparts (46). When DNA is unwound by negative super-
coiling, minor-groove width is increased (47). Thus, in the
negativelysupercoiledcircularDNA,negativewrithecould
be accumulated locally in GC-rich regions that can accept
the wide minor groove. In other words, these segments
of DNA have narrower major groove as compared to
linear DNA, which can be used as a characteristic signa-
ture for negative superhelical conﬁguration. If this is the
case, the lysine–guanine and glutamic/aspartic acid–
cytosine interactions through hydrogen bonding in the
major groove (40) may favor the major groove with
narrower-than-normal width, which may be ubiquitous in
negative supercoils. Use of minor groove binders with dif-
ferent base preference, GC-selective chromomycin A3 and
AT-selective distamycin A, gave clearly contrasting results.
The preferential binding of SRD to supercoiled DNA was
strongly interfered by chromomycin A3 but not by
distamycin A. These results not only support the involve-
ment of SRD core in the supercoil recognition but also
imply that SRD has a direct contact in the major groove
of GC-rich regions that arescattered in negative supercoils.
The reason why the binding of chromomycin to minor
groove interferes with the binding of SRD in major
groove (opposite side of the duplex) could be ascribed to
a propagation effect: changes in the major groove size
induced by the widening of minor groove by chromomycin
binding (48) or induced perturbation of electron density
around the ring system of bases, which may disfavor the
hydrogen bonding with SRD in the major groove. There is
no evidence so far suggesting that the interaction between
SRD and supercoiled DNA is based on some unpaired
bases or single-stranded regions in non-B DNA structures
like cruciform, triplex, or quadruplex that are known to be
stabilized under negative superhelicity.
We have shown in the present study that SRD appears
to be a primary determinant for SBP75/LEDGF to locate
at active transcription sites in nuclei, probably by
recognizing superhelical DNA regions generated at tran-
scription sites. A recent report conﬁrmed that negative
supercoils remain intact in vivo for substantial period of
time even in the presence of DNA relaxing enzymes such
as DNA topoisomerases (28). Both endogenous and tran-
siently expressed SBP75/LEDGF were detected in
H3K4me3-positive or Br-UTP-incorporated regions
where transcription was supposed to be active. However,
SBP75/LEDGF protein associated with H3K4me3-
positive region was not relatively abundant and large
population of the protein located in condensed chromatin
regions, being consistent with previous studies (5,9,22).
This is due to the fact that the N-terminal PWWP
domain exerts a dominating effect on the protein’s intra-
nuclear localization (22,23). We conﬁrmed this by using
PWWP deletion mutants that diffusely distributed in the
nucleus and were quite mobile upon ﬁxation (Figure 6 and
Supplementary Figure S8). Recently, the PWWP domain
identiﬁed in several proteins was shown to be involved in
recognition of methylated histones. The PWWP domain
of Pdp1 (Schizosaccharomyces pombe protein PWWP
domain protein 1) binds to histone H4 methylated on
Lys20 (49). Histone H3 trimethylated on Lys36 is rec-
ognized by human BRPF1 (boromo and plant homeo-
domain ﬁnger-containing protein 1) (50) and by murine
Dnmt3a DNA methyltransferase (51) through the inter-
action with their PWWP domains. Therefore, this domain
seems to target either transcriptionally active (H3K36me3)
or inactive (H4K20me) signatures, probably depending
on its structural difference among each protein. It is not
yet clear whether the PWWP domain of SBP75/LEDGF
recognizes methylated histones or other unknown
modiﬁcations enriched in heterochromatic regions.
The apparent discrepancy between the subnuclear dis-
tribution and the DNA-binding proﬁles of SBP75/
LEDGF in vivo was also reported recently. When
LEDGF fused to E. coli Dam methylase was expressed
in HeLa cells, the protein showed a typical distribution
pattern in the nucleus, being mostly overlapped with
condensed chromatin regions that are supposed to have
Nucleic Acids Research, 2011,Vol.39, No. 12 5079a low transcriptional level. However, determination of
DNA sites bound by the protein, as mapped in the
ENCODE region by the DamID technique, revealed
that most frequent sites are transcription units of active
genes (52). The LEDGF-bound chromatin islands also
correlated well with the HIV-1 integration sites (52). It is
very likely that only a small fraction of SBP75/LEDGF is
targeted to transcription active chromatin sites and the
protein’s ability to recognize superhelical structure
would be a driving force for targeting (schematically
shown in Figure 7). It is not clear at present whether the
PWWP domain has a speciﬁc interaction partner at the
tethered chromatin sites and why so much proportion of
the protein is tethered there. If the afﬁnity of SRD to
supercoils were not strong enough, the protein would
have to be untethered before interacting with active chro-
matin. The view is consistent with the recent report with a
combination of real-time quantitative ﬂuorescence tech-
niques demonstrating that SBP75/LEDGF dynamically
moves between scanning and locked states and PWWP
domain is crucial for locking the partner-loaded protein
on chromatin (53). After all the preferential recognition of
and binding to supercoiled DNA by SBP75/LEDGF
could be an underlying molecular mechanism of preferen-
tial integration of HIV-1 cDNA into active transcription
units.
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